Miyuki Okura, Naoko Hosono, Takahiro Yamauchi (Department of Hematology and Ondology, University of Fukui, Fukui, Japan)
Session information
Oral Session
Oral Session 3-9D Multiple Myeloma: Prognostic Factors
Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.9 (Tokyo International Forum, 4F G402)
Chair: Makoto Sasaki (Department of Hematology, Juntendo University)
[OS3-9D-2] Lymphocyte counts after lenalidomide initiation influence the outcome of patients with MM
Takuto Ishikawa1, Noriyoshi Iriyama1, Masaru Nakagawa1, Katsuhiro Miura1, Yoshihito Uchino1, Hiromichi Takahashi1,2, Takashi Hamada1, Kazuhide Iizuka1, Takashi Koike1, Kazuya Kurihara1, Atsuto Noguchi1, Yoshikazu Iizuka1, Yoshihiro Hatta1, Tomohiro Nakayama2, Masami Takei1 (1.Hematol & Rheumatol., Nihon Univ., Tokyo, Japan, 2.Department of Pathology and Microbiology, Nihon Univ., Tokyo, Japan)
Yoshiaki Abe1, Sho Ikeda2, Akihiro Kitadate1, Toshiki Terao1, Kosei Matsue1 (1.Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan, 2.Hematol., Akita Univ., Akita, Japan)
Shiori Kinoshita, Masaki Ri, Takuto Tachita, Arisa Asano, Takashi Kanamori, Sho Aoki, Haruhito Totani, Tomoko Narita, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida (Hematol and Oncol., Nagoya City Univ., Nagoya, Japan)
Hiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, Yoshiaki Abe, Kentaro Narita, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kosei Matsue (Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center)
Katsuhiro Io, Tomoya Kitagawa, Shojiro Inano, Tomomi Oka, Hirokazu Hirata, Kenichi Nagai (Hematology, Kansai Electric Power Hospital, Osaka, Japan)